Organisation paid for research Program year 2024 Source: CMS Open Payments

Anthony Mills, MD Inc.

Neither a doctor nor a teaching hospital

Research payments

$24,551

8 payments

Through program year 2024, Anthony Mills, MD Inc. is reported as receiving $24,551 in research payments, across 8 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2024	Research	$19,372	2
2020	Research	$5,179	6

Breakdown

Who paid Research payments · program years 2020–2024

Merck Sharp & Dohme Corporation $24,551 8 payments

Studies the money was for Research payments · program years 2020–2024

A Phase 3 Multicenter, Double-Blind, Randomized, Active Comparator-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Doravirine MK-1439 100 mg Once Daily Versus Darunavir 800 mg Once Daily plus Ritonavir 100 mg Once Daily, Each in Combination with TRUVADA or EPZICOM ,KIVEXA , in Treatment-Na ve HIV-1 Infected Subjects $23,603 3 payments
A Phase 2 Clinical Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Doravirine,Islatravir in Pediatric Participants with HIV-1 Infection who are Virologically Suppressed or Treatment-Na ve, are Less Than 18 Years of Age, and Weigh Greater Than or Equal to 35 kg $500 1 payment
A Phase 3 Multicenter, Double-Blind, Randomized, Active Comparator-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Doravirine MK-1439 100 mg Once Daily Versus Darunavir 800 mg Once Daily plus Ritonavir 100 mg Once Daily, Each in Combination with TRUVADA or EPZICOM ,KIVEXA , in Treatment-Na ve HIV-1 Infected Subjects $448 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.